Lineage (NASDAQ:LINE) Azioni

Lineage

Linn Energy

Linn Energy, LLC

NASDAQ

Lineage Inc is a temperature-controlled warehouse real estate investment trust. It operates an interconnected global temperature-controlled warehouse network, comprising approximately millions of square feet across several warehouses predominantly located in densely populated critical-distribution markets across North America, Asia-Pacific, and Europe. The company's reportable segments are Global Warehousing, which utilizes the company's industrial real estate properties to provide temperature-controlled warehousing services to its customers, and Global Integrated Solutions, which complements Global Warehousing with specialized cold-chain services. Maximum revenue is generated from the Global Warehousing segment. Geographically, the company derives its key revenue from the United States.

Online,Real,Estate,Property,Search,And,Web,Listing

Long Ideas

News

Pre-Market Outlook

Markets

Trading Ideas

LINE

Tre società con indicatori RSI che suggeriscono una possibile sottovalutazione e un potenziale rialzo nel prossimo futuro.

Affari nel settore immobiliare: 3 azioni che potrebbero essere sottovalutate

Lineage Inc

LINEA DIRECTA ASEGURADORA by LINEA DIRECTA ASEGURADORA SA

Linea Directa Aseguradora SA

Lineage Cell Therapeutics, Inc. Common Stock

Lineage Cell Therapeutics Inc

Linear Finance

LINEAR MINERALS CORP by LINEAR MINERALS CORP.

Linear Minerals Corp

Wells Fargo analyst Blaine Heck maintains Lineage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LINE#NASDAQ">LINE</a>) with a Equal-Weight and lowers the price target from $64 to $48.

Price Target

Analyst Ratings

Wells Fargo Maintains Equal-Weight on Lineage, Lowers Price Target to $48

Scotiabank analyst Greg McGinniss maintains Lineage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LINE#NASDAQ">LINE</a>) with a Sector Perform and lowers the price target from $56 to $50.

Scotiabank Maintains Sector Perform on Lineage, Lowers Price Target to $50

Goldman Sachs analyst Caitlin Burrows maintains Lineage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LINE#NASDAQ">LINE</a>) with a Buy and lowers the price target from $74 to $63.

Goldman Sachs Maintains Buy on Lineage, Lowers Price Target to $63

BofA Securities analyst Jeffrey Spector downgraded Lineage Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LINE#NASDAQ">LINE</a>) to Neutral from Buy on Tuesday and lowered the price forecast <a target="_blank" href="https://www.benzinga.com/quote/LINE/analyst-ratings" rel="noreferrer noopener">from $70.00 to $49.00</a>.
The analyst downgraded LINE and lowered the price target, citing reduced visibility driven by persistent revenue growth challenges, halted supply chain investments, and downward earnings revisions.
Spector noted that producers are delaying key decisions on expansions, plant locations, and transportation sourcing due to macroeconomic uncertainty driven by tariffs.
Lineage reported first-quarter 2025 EPS of $0.01, exceeding analyst expectations of a $ 0.05 loss, and posted revenue of $1.29 billion, which fell short of the $1.34 billion consensus estimate.
The Company <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/b45093641/lineage-inc-announces-first-quarter-2025-financial-results-and-landmark-agreements-with-long-term-" rel="noreferrer noopener">maintains its full-year 2025</a> outlook, projecting adjusted EBITDA between $1.35 billion and $1.40 billion, and adjusted FFO per share in the range of $3.40 to $3.60.
The analyst stated that Lineage reported Q1 AFFO of $0.86, surpassing both their $0.80 estimate and the $0.85 consensus. However, revenue declined 4.2% compared to their projected 2.1% growth, driven by lower occupancy, reduced throughput volumes, and softer pricing in both storage and services.
Spector added that the 2025 AFFO guidance was upheld, partly due to recent acquisitions, including the Tyson Foods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSN#NYSE">TSN</a>) <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/b45093569/lineage-inc-announces-plans-to-expand-its-u-s-cold-storage-network-with-long-time-customer" rel="noreferrer noopener">deal</a>.
The analyst lowered the 2025 occupancy growth forecast to -1.7% from -0.6% and reduced 2025 throughput volume growth to -1.6% from +1.5%. 2026 occupancy growth remains flat, with throughput growth revised down to +0.3% from +1.5%.
The analyst revised 2025 occupancy growth down to -1.7% from -0.6%, and reduced throughput volume growth to -1.6% from +1.5%. For 2026, occupancy growth is expected to remain flat, while throughput growth is now forecasted at +0.3%, down from +1.5%.
Here are other recent <a target="_blank" href="https://www.benzinga.com/quote/LINE/analyst-ratings" rel="noreferrer noopener">analyst ratings</a> on Lineage and their price targets:
<ul>
<li>Piper Sandler: Maintained an Overweight rating, lowered price target from $75 to $60</li>
<li>Baird: Maintained Outperform rating, lowered price target from $70 to $64</li>
<li>Evercore ISI Group: Maintained an Inline rating, lowered price target from $68 to $59</li>
<li>UBS: Maintained Neutral rating, lowered price target from $62 to $49</li>
</ul>
Price Action: LINE shares closed lower by 1.13% to $43.78 on Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/05/45238222/teslas-future-hinges-on-china-fsd-analyst-says" target="_blank" rel="noreferrer noopener">Tesla&#8217;s Future Hinges On China FSD: Goldman Sachs</a></li>
</ul>
Photo via Shutterstock

Analyst Color

Earnings

Downgrades

Movers

Lineage Stock Forecast Slashed By 30% - Here's Why

Lineage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LINE#NASDAQ">LINE</a>) has been analyzed by 12 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">8</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Lineage and provided 12-month price targets. The average target is $64.92, accompanied by a high estimate of $75.00 and a low estimate of $49.00. Highlighting a 13.32% decrease, the current average has fallen from the previous average price target of $74.90. 
<img src="https://www.benzinga.com/files/images/story/2025/1746471673_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The standing of Lineage among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Alex Goldfarb</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$60.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Michael Goldsmith</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$49.00</td>
<td>$62.00</td>
</tr>
<tr>
<td>Steve Sakwa</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>In-Line</td>
<td>$59.00</td>
<td>$68.00</td>
</tr>
<tr>
<td>Nicholas Thillman</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$64.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Greg McGinniss</td>
<td>Scotiabank</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$56.00</td>
<td>$74.00</td>
</tr>
<tr>
<td>Brendan Lynch</td>
<td>Barclays</td>
<td>Announces</td>
<td>Overweight</td>
<td>$59.00</td>
<td>-</td>
</tr>
<tr>
<td>Ronald Kamdem</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$75.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Craig Mailman</td>
<td>Citigroup</td>
<td>Announces</td>
<td>Neutral</td>
<td>$64.00</td>
<td>-</td>
</tr>
<tr>
<td>Greg McGinniss</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Outperform</td>
<td>$74.00</td>
<td>$73.00</td>
</tr>
<tr>
<td>Michael Carroll</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$74.00</td>
<td>$81.00</td>
</tr>
<tr>
<td>Nicholas Thillman</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$70.00</td>
<td>$76.00</td>
</tr>
<tr>
<td>Alex Goldfarb</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$75.00</td>
<td>$90.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Lineage. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Lineage compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Lineage's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Lineage's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/LINE/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Lineage analyst ratings.</a>
<h2>Unveiling the Story Behind Lineage</h2>
Lineage Inc is a temperature-controlled warehouse real estate investment trust. It operates an interconnected global temperature-controlled warehouse network, comprising approximately millions of square feet across several warehouses predominantly located in densely populated critical-distribution markets across North America, Asia-Pacific, and Europe. The company's reportable segments are Global Warehousing, which utilizes the company's industrial real estate properties to provide temperature-controlled warehousing services to its customers, and Global Integrated Solutions, which complements Global Warehousing with specialized cold-chain services. Maximum revenue is generated from the Global Warehousing segment. Geographically, the company derives its key revenue from the United States.
<h3>Unraveling the Financial Story of Lineage</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Negative Revenue Trend: Examining Lineage's financials over 3M reveals challenges. As of 31 March, 2025, the company experienced a decline of approximately -2.71% in revenue growth, reflecting a decrease in top-line earnings. When compared to others in the Real Estate sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Lineage's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 0.15%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Lineage's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 0.02%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Lineage's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.01%, the company may face hurdles in achieving optimal financial returns.
Debt Management: Lineage's debt-to-equity ratio is below the industry average. With a ratio of 0.83, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>How Are Analyst Ratings Determined?</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What 12 Analyst Ratings Have To Say About Lineage

Piper Sandler analyst Alex Goldfarb maintains Lineage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LINE#NASDAQ">LINE</a>) with a Overweight and lowers the price target from $75 to $60.

Piper Sandler Maintains Overweight on Lineage, Lowers Price Target to $60

These large-cap stocks were the worst performers in the last week. Are they in your portfolio?
<ol>
<li>Block, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYZ#NYSE">XYZ</a>) shares tumbled 19.90% after the company reported <a href="https://www.benzinga.com//node/45152696" target="_blank" rel="noreferrer noopener">worse-than-expected financial results</a>. Analysts slashed <a href="https://www.benzinga.com/quote/xyz/analyst-ratings" target="_blank" rel="noreferrer noopener">the price forecast on the stock</a>.</li>
<li>Lineage, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LINE#NASDAQ">LINE</a>) shares fell 18.93% after reporting worse-than-expected <a href="https://www.benzinga.com//node/45093641" target="_blank" rel="noreferrer noopener">first-quarter sales results</a>. Some analysts lowered the <a href="https://www.benzinga.com/quote/line/analyst-ratings" target="_blank" rel="noreferrer noopener">price forecast on the stock</a>.</li>
<li>Becton, Dickinson and Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BDX#NYSE">BDX</a>) stock dipped 17.70%  after the company cut FY25 EPS guidance despite a hike in sales outlook. The company also missed <a href="https://www.benzinga.com//node/45140102" target="_blank" rel="noreferrer noopener">second-quarter revenue estimates</a>. Analysts cut <a href="https://www.benzinga.com/quote/bdx/analyst-ratings" target="_blank" rel="noreferrer noopener">the price forecast on the stock</a>.</li>
<li>Coca-Cola (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COKE#NASDAQ">COKE</a>) shares decreased 16.36%  after the company reported a year-over-year decrease in <a href="https://www.benzinga.com//node/45116927" target="_blank" rel="noreferrer noopener">first-quarter financial results</a>.</li>
<li>Westlake Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) stock fell 14.50% after the company reported worse-than-expected <a href="https://www.benzinga.com//node/45161312" target="_blank" rel="noreferrer noopener">first-quarter sales results</a>.</li>
<li>Pilgrim&#8217;s Pride Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PPC#NASDAQ">PPC</a>) stock dived 13.84% after the company reported worse-than-expected <a href="https://www.benzinga.com//node/45118399" target="_blank" rel="noreferrer noopener">first-quarter financial results</a>.</li>
<li>Ecopetrol S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EC#NYSE">EC</a>) shares declined 12.27% probably amid a drop in oil and natural gas prices following a decline in U.S. first-quarter GDP, which could weigh on demand outlook.</li>
<li>Alamos Gold Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGI#NYSE">AGI</a>) shares were down 11.59% after the company reported <a href="https://www.benzinga.com//node/45119634" target="_blank" rel="noreferrer noopener">first-quarter results below estimates</a>. The stock may also be down amid a drop in gold spot price.</li>
<li>YPF Sociedad Anonima (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YPF#NYSE">YPF</a>) stock fell 9.09%.</li>
<li>Targa Resources, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRGP#NYSE">TRGP</a>) stock dived 8.87% after the company reported <a href="https://www.benzinga.com//node/45128247" target="_blank" rel="noreferrer noopener">earnings for the first quarter</a>.</li>
</ol>
Photo via Shutterstock

Equities

Large Cap

COKE

FSLR

TRGP

Block, Becton Dickinson And Pilgrim's Pride Are Among Top 10 Large-Cap Losers Last Week (Apr 28-May 2): Are The Others In Your Portfolio?

UBS analyst Michael Goldsmith maintains Lineage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LINE#NASDAQ">LINE</a>) with a Neutral and lowers the price target from $62 to $49.

UBS Maintains Neutral on Lineage, Lowers Price Target to $49

The most oversold stocks in the real estate sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Whitestone REIT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WSR#NYSE">WSR</a>)</h3>
<ul>
<li>On April 30, Whitestone REIT posted weaker-than-expected results for the first quarter. &#8220;Whitestone delivered a very strong quarter, delivering 4.8% Same Store Net Operating Income growth, GAAP leasing spreads of 20.3% and occupancy of 92.9%. Our portfolio of primarily service-based tenants is designed to adapt more readily to change and deliver results in a variety of economic environments,&#8221; said Dave Holeman, Chief Executive Officer. The company's stock fell around 14% over the past month and has a 52-week low of $11.37.</li>
<li>RSI Value: 26.7</li>
<li>WSR Price Action: Shares of Whitestone fell 3.5% to close at $12.54 on Thursday.</li>
<li>Edge Stock Ratings: 52.46 Momentum score with Value at 59.74. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/quote/wsr"><img loading="lazy" decoding="async" width="485" height="178" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/02040719/image-17.png" alt="" class="wp-image-898519" style="width:360px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/02040719/image-17.png 485w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/02040719/image-17-300x110.png 300w" sizes="(max-width: 485px) 100vw, 485px" /></a></figure>
<h3 class="wp-block-heading">Lineage Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LINE#NASDAQ">LINE</a>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</h3>
<ul>
<li>On April 30, Lineage reported worse-than-expected first-quarter sales results. The company's stock fell around 19% over the past month and <a href="https://www.benzinga.com/quote/LINE">has a 52-week low </a> of $46.30.</li>
<li>RSI Value: 29.6</li>
<li>LINE Price Action: Shares of Lineage dipped 2.1% to close at $47.22 on Thursday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the trend in <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0502">LINE stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0502"><img loading="lazy" decoding="async" width="920" height="842" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/02040820/image-18.png" alt="" class="wp-image-898520" style="width:568px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/02040820/image-18.png 920w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/02040820/image-18-300x275.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/02040820/image-18-768x703.png 768w" sizes="(max-width: 920px) 100vw, 920px" /></a></figure>
<h3 class="wp-block-heading">Rayonier Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RYN#NYSE">RYN</a>)</h3>
<ul>
<li>On April 30, Rayonier reported worse-than-expected first-quarter financial results and cut its FY25 EPS guidance. &#8220;We continued to advance key strategic initiatives during the first quarter, underscored by our announcement of an agreement to sell our New Zealand joint venture interest in March,&#8221; said Mark McHugh, President and CEO. The company's stock fell around 16% over the past month and has a 52-week <a href="https://www.benzinga.com/quote/RYN">low of $22.80</a>.</li>
<li>RSI Value: 26.5</li>
<li>RYN Price Action: Shares of Rayonier fell 3.6% to close at $23.59 on Thursday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential breakout in <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0502">RYN shares</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0502"><img loading="lazy" decoding="async" width="885" height="793" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/02040932/image-19.png" alt="" class="wp-image-898521" style="width:598px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/02040932/image-19.png 885w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/02040932/image-19-300x269.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/02040932/image-19-768x688.png 768w" sizes="(max-width: 885px) 100vw, 885px" /></a></figure>
Learn more about BZ Edge Rankings—click to see scores for other stocks in the sector and s<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">ee how they compare.</a> 
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/05/45133450/jim-cramer-this-consumer-cyclical-stock-is-a-one-trick-pony">Jim Cramer: This Consumer Cyclical Stock Is A &#8216;One-Trick Pony&#8217;</a> </li>
</ul>
Photo via Shutterstock

Top 3 Real Estate Stocks That May Rocket Higher This Month

Evercore ISI Group analyst Steve Sakwa maintains Lineage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LINE#NASDAQ">LINE</a>) with a In-Line and lowers the price target from $68 to $59.

Evercore ISI Group Maintains In-Line on Lineage, Lowers Price Target to $59

Baird analyst Nicholas Thillman maintains Lineage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LINE#NASDAQ">LINE</a>) with a Outperform and lowers the price target from $70 to $64.

Baird Maintains Outperform on Lineage, Lowers Price Target to $64

WIIM

Lineage shares are trading lower after the company reported worse-than-expected Q1 sales results.

Lineage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LINE#NASDAQ">LINE</a>) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.05) by 120 percent. This is a 103.57 percent increase over losses of $(0.28) per share from the same period last year. The company reported quarterly sales of $1.29 billion which missed the analyst consensus estimate of $1.34 billion by 3.49 percent. This is a 2.71 percent decrease over sales of $1.33 billion the same period last year.

Earnings Beats

Earnings Misses

Lineage Q1 GAAP EPS $0.01 Beats $(0.05) Estimate, Sales $1.29B Miss $1.34B Estimate

Lineage To Acquire Tyson Foods Cold Storage Warehouses, Invest $1B In U.S. Expansion And Automation Push

AEIS

ALGN

ALKT

AMCR

ANSS

ARAY

ATNI

AWRE

BLCO

BLFY

BLKB

BXMT

CACC

CAKE

CDNA

CFLT

CGNX

CHEF

CHRW

CLMB

CMPR

CNMD

CNXN

COCO

CPSH

CSLR

CSTM

CTOS

CTSH

CVEO

CWAN

CWEN

DFIN

EBAY

ENVX

EQIX

EQNR

ETSY

EXTR

FCPT

FFWM

FINW

FMBH

FORM

FTAI

GEHC

GKOS

GNRC

GRBK

GRMN

GTES

Earnings Scheduled For April 30, 2025

Scotiabank analyst Greg McGinniss downgrades Lineage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LINE#NASDAQ">LINE</a>) from Sector Outperform to Sector Perform and lowers the price target from $74 to $56.

Scotiabank Downgrades Lineage to Sector Perform, Lowers Price Target to $56

Barclays analyst Brendan Lynch initiates coverage on Lineage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LINE#NASDAQ">LINE</a>) with a Overweight rating and announces Price Target of $59.

Initiation

Barclays Initiates Coverage On Lineage with Overweight Rating, Announces Price Target of $59

Lineage Acquires Bellingham Cold Storage; Financial Terms Not Disclosed

Morgan Stanley analyst Ronald Kamdem maintains Lineage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LINE#NASDAQ">LINE</a>) with a Overweight and lowers the price target from $80 to $75.

Morgan Stanley Maintains Overweight on Lineage, Lowers Price Target to $75

In the preceding three months, 8 analysts have released ratings for Lineage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LINE#NASDAQ">LINE</a>), presenting a wide array of perspectives from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">5</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $71.75, a high estimate of $77.00, and a low estimate of $64.00. Experiencing a 12.04% decline, the current average is now lower than the previous average price target of $81.57. 
<img src="https://www.benzinga.com/files/images/story/2025/1743170453_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Lineage. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Craig Mailman</td>
<td>Citigroup</td>
<td>Announces</td>
<td>Neutral</td>
<td>$64.00</td>
<td>-</td>
</tr>
<tr>
<td>Greg McGinniss</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Outperform</td>
<td>$74.00</td>
<td>$73.00</td>
</tr>
<tr>
<td>Michael Carroll</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$74.00</td>
<td>$81.00</td>
</tr>
<tr>
<td>Nicholas Thillman</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$70.00</td>
<td>$76.00</td>
</tr>
<tr>
<td>Alex Goldfarb</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$75.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Greg McGinniss</td>
<td>Scotiabank</td>
<td>Lowers</td>
<td>Sector Outperform</td>
<td>$73.00</td>
<td>$76.00</td>
</tr>
<tr>
<td>Caitlin Burrows</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Buy</td>
<td>$77.00</td>
<td>$89.00</td>
</tr>
<tr>
<td>Vikram Malhotra</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$67.00</td>
<td>$86.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Lineage. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Lineage compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Lineage's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Lineage's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/LINE/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Lineage analyst ratings.</a>
<h2>Unveiling the Story Behind Lineage</h2>
Lineage Inc is a temperature-controlled warehouse real estate investment trust. It operates an interconnected global temperature-controlled warehouse network, comprising approximately millions of square feet across several warehouses predominantly located in densely populated critical-distribution markets across North America, Asia-Pacific, and Europe. The company's reportable segments are Global Warehousing, which utilizes the company's industrial real estate properties to provide temperature-controlled warehousing services to its customers, and Global Integrated Solutions, which complements Global Warehousing with specialized cold-chain services. Maximum revenue is generated from the Global Warehousing segment. Geographically, the company derives its key revenue from the United States.
<h3>Key Indicators: Lineage's Financial Health</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: Over the 3 months period, Lineage showcased positive performance, achieving a revenue growth rate of 0.37% as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Real Estate sector.
Net Margin: Lineage's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of -5.3%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Lineage's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of -0.8%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Lineage's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of -0.37%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: Lineage's debt-to-equity ratio is below the industry average. With a ratio of 0.8, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>Analyst Ratings: Simplified</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

8 Analysts Have This To Say About Lineage

Press Releases

LINE Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - LINE

LINE Investors Have Opportunity to Join Lineage, Inc. Fraud Investigation with the Schall Law Firm

Lineage, Inc. Declares Dividend for First Quarter 2025

LINE Investors Are Encouraged to Inquire About the Lineage, Inc. Fraud Investigation with the Schall Law Firm

Lineage Announces Acquisition of Bellingham Cold Storage

Lineage to Report First-Quarter 2025 Financial Results on April 30, 2025

Lineage Names ATS Intermodal a 2024 Carrier of the Year Award Winner

Lineage, Inc. Announces Plans to Expand Its U.S. Cold-Storage Network With Long-Time Customer

Lineage, Inc. Announces First-Quarter 2025 Financial Results and Landmark Agreements With Long-Term Customer

Comments

Lineage

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO